Cargando…

AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119608/ http://dx.doi.org/10.1007/s40278-021-95684-3

Ejemplares similares

Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
por: Reynolds, Lia, et al.
Publicado: (2023)

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
por: Whitaker, Heather J., et al.
Publicado: (2022)

Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
por: Phumisantiphong, Uraporn, et al.
Publicado: (2023)

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
por: Eyre, David W., et al.
Publicado: (2021)

Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum
por: Kaura, Amit, et al.
Publicado: (2022)

The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence
por: Rosero-Bixby, Luis
Publicado: (2022)

"Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)
por: Samir, Ahmed, et al.
Publicado: (2023)

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)

Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)

Pfizer-BioNTech COVID-19 vaccine safe with clozapine
Publicado: (2022)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021)

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia
Publicado: (2021)

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine in patients with severe allergies
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans
Publicado: (2021)

Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
Publicado: (2021)

Evaluation of S1RBD-Specific IgG Antibody Responses following COVID-19 Vaccination in Healthcare Professionals in Cyprus: A Comparative Look between the Vaccines of Pfizer-BioNTech and AstraZeneca
por: Deeba, Elie, et al.
Publicado: (2022)

Pfizer-BioNTech COVID-19 vaccine: AEs after vaccination in New Zealand
Publicado: (2021)

Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Publicado: (2022)

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
Publicado: (2021)

Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination
Publicado: (2021)

Nursing home resident deaths after Pfizer-BioNTech's COVID-19 vaccine
Publicado: (2021)

No increase in stroke, MI or PE after Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination()
por: Bracho-Borro, Maria, et al.
Publicado: (2023)

Side Effects of COVID-19 Vaccines (Pfizer, AstraZeneca) in Saudi Arabia, Eastern Province
por: Ibrahim Amer, Fatma Hamza, et al.
Publicado: (2022)

Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study
por: Lukaszuk, Krzysztof, et al.
Publicado: (2022)

Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study
por: Aldali, Jehad, et al.
Publicado: (2023)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
por: Callaghan, Chris J., et al.
Publicado: (2022)

Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
por: Adjobimey, Tomabu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h39g9v675rs6it8dkac416ujh4